Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Patient Information Leaflet last updated on the eMC: 23/12/2011
PIL Avastin 25mg/ml concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Change to side-effects
Updated on 02/12/2011 and displayed until 23/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 05/08/2011 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/07/2011 and displayed until 05/08/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 07/03/2011 and displayed until 08/07/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 11/01/2011 and displayed until 07/03/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/09/2010 and displayed until 11/01/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 20/07/2010 and displayed until 08/09/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 10/06/2010 and displayed until 20/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/01/2010 and displayed until 10/06/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to storage instructions
  • Change to side-effects
Updated on 22/01/2010 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to storage instructions
  • Change to side-effects
Updated on 30/07/2009 and displayed until 22/01/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/04/2009 and displayed until 30/07/2009
Reasons for adding or updating:
  • Change of contra-indications
Updated on 11/09/2008 and displayed until 01/04/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/02/2008 and displayed until 11/09/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 29/01/2008 and displayed until 12/02/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 12/12/2007 and displayed until 29/01/2008
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/11/2007 and displayed until 12/12/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/09/2007 and displayed until 12/11/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
Updated on 03/05/2007 and displayed until 25/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 13/04/2007 and displayed until 03/05/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 19/07/2006 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 11/01/2006 and displayed until 19/07/2006
Reasons for adding or updating:
  • Change to date of revision
  • Improved Electronic Presentation
Updated on 14/03/2005 and displayed until 11/01/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   bevacizumab